Prospects and challenges of noncoding-RNA-mediated inhibition of heat shock protein 90 for cancer therapy
{{output}}
Heat Shock Protein 90 (HSP90) is a potential drug target for cancer therapy as it is often dysregulated in several cancers, including lung, breast, pancreatic, and prostate cancers. In cancer, HSP90 fails to maintain the structural and functional integrity of ... ...
